Maybe the reason Dodd, Esposito, and others decide to not bid on the technology is because they find it has limited value. The signs were there. FDA approval wasn't needed for foreign sales, yet all we heard was no one would buy it without FDA approval. Looking like no one wants to buy these systems period.